OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES. Mediterr J Hematol Infect Dis [Internet]. 2026 Feb. 28 [cited 2026 Jun. 10];18(1). Available from: https://www.mjhid.org/mjhid/article/view/6210